✦ LIBER ✦

The treatment of depression with L-5-Hydroxytryptophan versus imipramine

✍ Scribed by J. Angst; B. Woggon; J. Schoepf

Publisher: Springer-Verlag
Year: 1977
Tongue: English
Weight: 662 KB
Volume: 224
Category: Article
ISSN: 1433-8491
DOI: 10.1007/bf00346485

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in auditory evoked responses and

Changes in auditory evoked responses and in the inhibitory action of 5-hydroxytryptophan following chronic treatment with imipramine in the rat

✍ M. J. Rowan; J. J. O'Connor; R. Anwyl 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 520 KB

The neurophysiological effects of acute and chronic treatment with the tricyclic antidepressant drug imipramine were investigated. Brainstem (BAER) and middle latency (MLR) auditory evoked responses were monitored in the alert and immobile rat. Daily injection of imipramine (10 mg/kg, IP) for 2 week

Treatment of myoclonus with l-5-hydroxyt

Treatment of myoclonus with l-5-hydroxytryptophan and carbidopa: Clinical, electrophusiological, and biochemical observations

✍ Dr. Leon J. Thal; Nansie S. Sharpless; Leslie Wolfson; Robert Katzman 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 619 KB

Decrease of the platelet 5-HT2A receptor

Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression

✍ Esther Gómez-Gil; Cristóbal Gastó; Marta Carretero; Maribel Díaz-Ricart; Manel S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

A double-blind comparison of the efficac

A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia

✍ Cornelius L. E. Katona; Brian N. Hunter; Julia Bray 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

Objectives. To compare the ecacy of paroxetine and imipramine prospectively in patients with coexisting depression and dementia. Methods. An 8-week, double-blind, parallel group trial comparing paroxetine 20±40 mg/day with imipramine 50±100 mg/day in 198 patients aged 60 years or over with a Montgo

The interaction of some kynurenine pathw

The interaction of some kynurenine pathway metabolites with 5-hydroxytryptophan and 5-hydroxytryptamine

✍ Sheila L. Handley; Ruth C. Miskin 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 411 KB

The kynurenine pathway metabolites kynurenine, 3-hydroxykynurenine and xanthurenic acid have been tested against 5-hydroxytryptamine (5-HT) and 5-hydroxytryptophan (5-HTP)-induced head twitches in the mouse in a dose-range of 0.5-5.0 mg/ kg. Kynurenine and 3-hydroxykynurenine were highly active. Low

Pramipexole versus sertraline in the tre

Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease

✍ P. Barone; L. Scarzella; R. Marconi; A. Antonini; L. Morgante; F. Bracco; M. Zap 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 310 KB